Linus Health

Cognitive decline remains one of the most feared and costly health challenges for patients and families. But if we can detect mild cognitive impairment (MCI) early, there are proven steps we can take to slow or even prevent its progression. The challenge has been finding a way to integrate that kind of monitoring into everyday primary care in a way that is both simple and effective. That’s where Linus Health comes in. Linus CEO David Bates, Chief Strategy Officer and primary care physician John Showalter, MD, and Chief Medical Officer and neurologist Alvaro Pascual-Leone, MD, recently gave The Health Care Blog’s Matthew Holt an in-depth demo of the Linus Health platform. They discussed the current state of neurology diagnosis, how our technology fits into the clinical workflow, and what the future holds for proactive brain health. Watch the full demo now: https://lnkd.in/gVsDMBHE I #CognitiveHealth #BrainHealth #AlzheimersDisease #EarlyDetection #MildCognitiveImpairment

What a fantastic time at CMGF 2025! The event sparked powerful conversations around ethical e-health, collaborative care for complex patients, and the future of cognitive care. One big takeaway? GPs are actively seeking digital tools that support early detection of mild cognitive impairment—and Linus really struck a chord.   We're thrilled to see the excitement around how Linus can support evolving care models. The future is bright! I #CMGF2025 #BrainHealth #DigitalHealth #PrimaryCare #HealthcareInnovation

New global projections indicate that Alzheimer’s and dementia cases are expected to double over the next 30 years—to 14 million in the U.S. and 152 million globally. How are AI-based digital cognitive assessments poised to change the way we detect and address these conditions? Michael McNutt, CMP from WEDI ’s The Collective Voice of Health IT Podcast chats with Linus Health Chief Strategy Officer Dr. John Showalter about the current state of early detection and management of cognitive disorders, barriers in traditional assessments and interoperability and how AI and innovation are enhancing assessments and improving patient outcomes. Tune in now! https://lnkd.in/equY8XhP I #CognitiveHealth #BrainHealth #AlzheimersDisease #EarlyDetection #MildCognitiveImpairment

More than 9 in 10 cases of mild cognitive impairment (MCI) go undetected, often because symptoms are subtle and routine checkups don’t always include cognitive assessments. Yet, detecting MCI early is crucial—it allows for interventions that may help slow progression and improve quality of life. Unlike widely available remote cognitive screeners, Anywhere for Health Systems™ delivers a clinically validated series of assessments that, along with specific insights to accurately identify early cognitive changes from home, ensures more people have access to the screenings they need without additional strain on busy clinics. https://lnkd.in/gidEA357 I #MCI #EarlyDetection #BrainHealthAwareness

AI has been at the center of discussions across the healthcare industry this year, especially at major trade shows where its potential to reshape care delivery continues to spark interest. At the RISE conference, Linus Health Chief Growth Officer Curt J. Thornton highlighted one promising application: using AI-powered digital cognitive assessments to detect signs of cognitive decline years earlier than traditional methods. He noted that cognitive decline and dementia are among the biggest drivers of healthcare costs. With a growing shortage of neurologists and primary care providers, innovations like these offer much-needed hope. Read on to see what Curt had to say: https://lnkd.in/gu6n4Bdb I #RISE2025 #BrainHealth #cognitiveHealth #AlzheimersDisease

Headed to AD/PD™ in Vienna next week? We’re pleased to share that we’ll be presenting findings from two new research studies—along with updates on our growth in the life sciences market—at the leading international conference for Alzheimer’s and Parkinson’s diseases. If you’re attending the conference, stop by stand #79 to learn more about how we evaluate the accuracy, efficacy, and value of our digital health solutions for detecting early indicators of cognitive and motor impairment. The research, led by Ali Jannati, MD, PhD, Linus Health’s Director of Cognitive Science, will also be available online as e-posters: ▶️ DCTclock Detects Cognitive and Motor Impairment in Parkinson’s Disease and Quantifies Drawing Tremor ▶️ Neuropsychological Validation of a Brief Protocol for Digital Assessment of Cognition Read more in the press release: https://lnkd.in/ghjPZgr5 I #ADPD25 #AlzheimersResearch #ClinicalTrials #Neuroscience #BrainHealthResearch Curt J. Thornton Seamus Small Stina Saunders Himanshi Malik

“As a caregiver, caring for yourself is a form of caring for your loved one. They do better when you feel better—and you’ll do better in the long run,” — John Showalter, MD, internal medicine physician and chief strategy officer at Linus Health. Dr. Showalter spoke with Verywell Mind about the importance of self-care for Alzheimer’s caregivers—and how to find the time for it. Caregiving increases the risk of chronic stress, burnout, anxiety, depression, and even physical health issues such as heart disease, cancer, and diabetes. Worse yet, neglecting self-care may also raise a caregiver’s dementia risk six-fold, regardless of age or genetics. Read more: https://lnkd.in/g49dwHVW I #Dementia #Caregiving #AlzheimersDisease #BrainHealth #SelfCare

For specialists like neurologists and neuropsychologists, understanding the nuances of cognitive function is critical for accurate diagnoses and treatment planning. Anywhere for Health Systems™ provides AI-enhanced analysis of key cognitive behaviors—such as response speed, verbal fluency, and hesitation patterns—offering additional context beyond traditional screenings. Validated research demonstrates that its battery produces results comparable to three hours of traditional neuropsychological testing. With these advanced insights, specialists can refine referrals, tailor evaluations, and provide more personalized care for patients experiencing cognitive concerns. https://lnkd.in/gpANVJRK I #NeuroHealth #CognitiveCare #BrainHealth #PrimaryCare #Neurology #MildCognitiveImpairment

Cognitive decline often starts subtly, making early detection challenging in busy primary care settings. Many providers recognize the importance of screening but struggle to find the time within routine exams. With a remote option like Anywhere for Health Systems™, patients can complete an evidence-based cognitive assessment at home and their provider will receive a detailed report with clear, actionable insights. This approach helps providers identify concerns earlier, refer patients more effectively, and ensure those who need specialized care receive it in a timely manner. Timely detection means more opportunities for support, intervention, and planning. https://lnkd.in/gpANVJRK I #PrimaryCare #CognitiveScreening #BrainHealthMatters

Millions of people with mild cognitive impairment (MCI) go undiagnosed each year, delaying access to early interventions that could help. Anywhere for Health Systems™ is a clinically validated, FDA-listed remote cognitive assessment designed to help detect cognitive changes earlier. The assessment evaluates multiple key cognitive domains and can be taken in-clinic and at home, reducing barriers to screening while providing accurate, actionable, research-backed insights for PCPs and specialists alike. Cognitive health is an important part of overall well-being, and early detection can make a difference. Learn more: https://lnkd.in/gpANVJRK I #CognitiveHealth #BrainHealth #EarlyDetection #CareAnywhere #AlzheimersDisease #MildCognitiveImpairment